Jerry Kurian

Integrated Synthetic, Biophysical and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α.

A. Mittermaier, Stephane De Cesco, N. Moitessier, 2019, Journal of medicinal chemistry.

Exploring Atypical Fluorine-Hydrogen Bonds and Their Effects on Nucleoside Conformations.

N. Moitessier, M. Damha, R. Stein, 2018, Chemistry.

Covalent inhibitors design and discovery.

Nicolas Moitessier, A. Mittermaier, Stephane De Cesco, 2017, European journal of medicinal chemistry.

Impact of COVID-19 on longitudinal ophthalmology authorship gender trends

A. Wu, Jerry Kurian, A. X. Nguyen, 2021, Graefe's Archive for Clinical and Experimental Ophthalmology.

Gender Gap in Neurology Research Authorship (1946–2020)

H. Moss, A. Wu, Jerry Kurian, 2021, Frontiers in Neurology.

3-Oxo-hexahydro-1H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors.

Nicolas Moitessier, A. Mittermaier, Stephane De Cesco, 2016, Journal of medicinal chemistry.

3-Oxo-hexahydro-1H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors.

A. Mittermaier, Stephane De Cesco, N. Moitessier, 2016, Journal of medicinal chemistry.